Page last updated: 2024-10-24

chromatin looping

Definition

Target type: biologicalprocess

A chromatin organization process that starts with the loading of an extrusion motor (by an SMC family complex) onto the chromatin, followed by chromatin extrusion that stops at loop anchoring sites on the chromosome. [PMID:32213323]

Chromatin looping is a fundamental process in eukaryotic cells that plays a crucial role in regulating gene expression. It involves the physical interaction of distant DNA segments, bringing them into close proximity within the nucleus. This process is mediated by specialized proteins known as chromatin remodelers and loop extrusion factors.

Chromatin remodelers are multi-protein complexes that utilize ATP hydrolysis to alter the structure of chromatin. They can slide nucleosomes along the DNA, reposition them, or even remove them entirely. These actions contribute to the accessibility of DNA to other regulatory proteins, including transcription factors and loop extrusion factors.

Loop extrusion factors, such as cohesin, are ring-shaped complexes that actively extrude DNA loops. They bind to DNA and then move along the DNA strand in a bidirectional manner, pulling the DNA through the ring. As the loop grows, the cohesin complex encounters other DNA segments, leading to the formation of DNA loops.

The formation of chromatin loops can bring together regulatory elements, such as enhancers and promoters, that are physically distant on the linear DNA sequence. This spatial proximity facilitates the interaction of transcription factors with their target genes, leading to changes in gene expression.

Chromatin looping is highly dynamic and can be regulated by various cellular signals. For example, changes in the expression levels of chromatin remodelers and loop extrusion factors, as well as the availability of ATP, can influence loop formation and stability. Additionally, post-translational modifications, such as phosphorylation and acetylation, can alter the activity of these proteins.

The formation of specific chromatin loops is essential for proper gene regulation and is involved in a wide range of cellular processes, including development, differentiation, and response to environmental stimuli. Disruptions in chromatin looping can contribute to various diseases, including cancer and developmental disorders.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Bromodomain-containing protein 2A bromodomain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P25440]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
ly 303511LY 303511: inhibitor of phosphatidylinositol 3-kinaseN-arylpiperazine
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first sourcechromones;
morpholines;
organochlorine compound
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
prazosinprazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
aromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
jq1 compoundcarboxylic ester;
organochlorine compound;
tert-butyl ester;
thienotriazolodiazepine
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
bromodomain-containing protein 4 inhibitor;
cardioprotective agent;
ferroptosis inducer
gsk525762amolibresib: mimicks acetylated histones; structure in first sourcebenzodiazepine
LSM-6732organonitrogen heterocyclic compound;
organosulfur heterocyclic compound;
tert-butyl ester
gsk1210151aGSK1210151A: inhibitor of the BET family of proteins; structure in first sourceimidazoquinoline
i-bet726
MZ1organic molecular entity
rvx 208apabetalone: a bromodomain and extra-terminal domain protein (BET) inhibitor; prevents interactions between BET proteins and acetyl-lysine residues on histone tails to modify epigenetic regulation